Literature DB >> 21859776

Knowledge of secondary prevention guidelines for coronary heart disease: results from a physicians' survey in China.

Jie Jiang1, Tao Hong, Ronghui Yu, Yan Zhang, Zhaopin Liu, Yong Huo.   

Abstract

BACKGROUND: There is gap between guideline requirements and clinical practice in coronary disease secondary prevention. A physician's awareness and familiarity are essential to put these guidelines in practice.
DESIGN: In 2007 a cross-sectional questionnaire survey was conducted among physicians from cardiology departments in 35 tertiary hospitals in China.
METHODS: The survey instrument contained questions to determine physicians' knowledge of guideline recommendations for coronary heart disease secondary prevention. These included treatment goals for blood pressure, dyslipidaemia and diabetes, lifestyle modifications and medication needs for secondary prevention. The criteria were based mainly on the AHA/ACC Guidelines for Secondary Prevention for Patients with Coronary and Atherosclerotic Vascular Disease (2006).
RESULTS: Responses from 837 physicians were deemed effective and were analysed. Knowledge of treatment goals for blood pressure, LDL and HbA1c were 80.8%, 84.2% and 36.2%, respectively; however, only 27.5% of the physicians chose all three goals correctly. Knowledge of lifestyle modification was poor among the physicians as only 2.3% of the physicians correctly answered all five questions about dietary therapy and aerobic exercise goals and requirements. In regard to the six basic questions related to medication, 87% answered correctly. Several specific questions had a much lower rate of being correct, showing that physicians' knowledge was not precise and current.
CONCLUSION: Knowledge of secondary prevention, especially lifestyle modification, for coronary disease was poor among this group of physicians from tertiary hospitals. Efforts must be made to educate physicians to improve their knowledge and improve patient care.

Entities:  

Mesh:

Year:  2011        PMID: 21859776     DOI: 10.1177/1741826711421299

Source DB:  PubMed          Journal:  Eur J Prev Cardiol        ISSN: 2047-4873            Impact factor:   7.804


  5 in total

Review 1.  Prevalence of cardiovascular medication on secondary prevention after myocardial infarction in China between 1995-2015: A systematic review and meta-analysis.

Authors:  Min Zhao; Kerstin Klipstein-Grobusch; Xin Wang; Johannes B Reitsma; Dong Zhao; Diederick E Grobbee; Ian Graham; Ilonca Vaartjes
Journal:  PLoS One       Date:  2017-04-20       Impact factor: 3.240

2.  An mHealth intervention to improve medication adherence among patients with coronary heart disease in China: Development of an intervention.

Authors:  Zhao Ni; Changqing Liu; Bei Wu; Qing Yang; Christian Douglas; Ryan Jeffrey Shaw
Journal:  Int J Nurs Sci       Date:  2018-09-08

3.  An mHealth Intervention to Improve Medication Adherence and Health Outcomes Among Patients With Coronary Heart Disease: Randomized Controlled Trial.

Authors:  Zhao Ni; Bei Wu; Qing Yang; Lijing L Yan; Changqing Liu; Ryan J Shaw
Journal:  J Med Internet Res       Date:  2022-03-09       Impact factor: 7.076

4.  Establishment and Validation of a Non-invasive Diagnostic Nomogram to Identify Heart Failure in Patients With Coronary Heart Disease.

Authors:  Juntao Tan; Yuxin He; Zhanbiao Li; Xiaomei Xu; Qinghua Zhang; Qian Xu; Lingqin Zhang; Shoushu Xiang; Xuewen Tang; Wenlong Zhao
Journal:  Front Cardiovasc Med       Date:  2022-04-07

5.  Gender-specific cardiovascular outcomes in patients undergoing percutaneous coronary intervention in Chinese populations.

Authors:  Juan Long; Fanfang Zeng; Lili Wang; Chen Yi; Qiying Chen; Honglei Zhao
Journal:  BMC Cardiovasc Disord       Date:  2020-06-09       Impact factor: 2.298

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.